John David Arkle, MS, LIMHP LIMFT | |
124 W 46th St Ste 2, Kearney, NE 68847-8348 | |
(308) 233-1995 | |
(308) 236-9013 |
Full Name | John David Arkle |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 124 W 46th St Ste 2, Kearney, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396757324 | NPI | - | NPPES |
47080518700 | Medicaid | NE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 23 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
John David Arkle, MS, LIMHP LIMFT 3110 12th Ave, Kearney, NE 68845-3337 Ph: (308) 233-1995 | John David Arkle, MS, LIMHP LIMFT 124 W 46th St Ste 2, Kearney, NE 68847-8348 Ph: (308) 233-1995 |
News Archive
Imagine a small paper device that can rapidly reveal from a drop of blood whether an infection is bacterial or viral. The device could help reduce the overuse of antibiotics – which kill bacteria, not viruses. Misuse of antibiotics has led to antimicrobial resistance, a growing global public health issue.
Cell Therapeutics, Inc. today announced that it has initiated its randomized pivotal trial of pixantrone for the treatment of relapsed/refractory diffuse large B-cell lymphoma ("DLBCL").
BioFire Diagnostics, Inc. announced today that it obtained the CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its FilmArray Blood Culture Identification Panel.
Tobacco companies have decided to sue the U.S. Food and Drug Administration (FDA) over a decision that has been made in regards to cigarettes. The companies include the R.J. Reynolds Tobacco Co. as well as Lorillard, Inc., have sued the FDA over a decision that would potentially ban all cigarettes that contain a chemical known as menthol.
› Verified 4 days ago